首页> 外文会议>26th Southern biomedical engineering conference >Measuring in vivo Effects of Chemotherapy Treatment on Cardiac Capillary Permeability
【24h】

Measuring in vivo Effects of Chemotherapy Treatment on Cardiac Capillary Permeability

机译:测量化学疗法对心脏毛细血管通透性的体内影响

获取原文
获取原文并翻译 | 示例

摘要

Background: Cardiotoxicity is a life-threatening side effect of chemotherapy that is multi-factorial in nature. Increased capillary permeability due to endothelial damage after anthracycline administration could be an important contributor to cardiac dysfunction. Methods: We investigated the cardiotoxic effects of the anthracycline doxorubicin (DOX) in rats using intraperitoneal injections of saline (n=10) or DOX (n=10) over 12 days for a cumulative dose of 18 mg/kg. We studied cardiotoxicity by serial echocardiography and with an isolated heart setup. We monitored perfusion and left ventricle pressures and measured permeability using a fluorescent indicator dilution method developed by our group. Results: There were significant differences (p=0.029) in permeability surface area product between control (0.047±0.009 cm~3/s) and DOX animals (0.068±0.025 cm~3/s). This is consistent with our hypothesis that chemotherapy-induced changes in the coronary capillary endothelium lead to increased permeability. We also observed changes in cardiac function consistent with chemotherapy-induced cardiotoxicity. Contractility (+dP/dt) and LVDP were significantly reduced (p = 0.030) in the DOX group. Average +dP/dt was 2465±183 mm Hg/s for controls vs. 1817±177 mm Hg/s for DOX-treated rats, and average LVDP was 92.4 mm Hg for controls vs. 78.7 mm Hg for DOX-treated rats. Fractional shortening (FS) echocardio-graphic measurements decreased significantly over the course of treatment for the DOX group (p = 0.028, end FS = 32.8%, n=5), but not for the control group (p = 0.209, end FS = 50.7%, n=5). Conclusion: Changes in permeability after chemotherapy treatment can be detected using a fluorescent indicator dilution method. These changes are consistent with other measures of cardiac function observed in the chemotherapy group. Efforts toward the development of chemotherapy drugs with reduced cardiotoxicity should consider the effect on the endothelial layer, and our method to measure permeability in an isolated heart setup could be useful during testing of new drug alternatives.
机译:背景:心脏毒性是化疗的一种危及生命的副作用,本质上是多因素的。蒽环类药物给药后由于内皮损伤引起的毛细血管通透性增加可能是导致心脏功能障碍的重要原因。方法:我们调查了蒽环霉素阿霉素(DOX)对大鼠的心脏毒性作用,使用腹膜内注射生理盐水(n = 10)或DOX(n = 10),历时12天,累积剂量为18 mg / kg。我们通过串行超声心动图和孤立的心脏设置研究了心脏毒性。我们使用我们小组开发的荧光指示剂稀释方法监测灌注和左心室压力以及通透性。结果:对照组(0.047±0.009 cm〜3 / s)和DOX动物(0.068±0.025 cm〜3 / s)的通透性表面积积有显着差异(p = 0.029)。这与我们的假设一致,即化学疗法诱发的冠状动脉毛细血管内皮变化导致通透性增加。我们还观察到心脏功能的变化与化疗引起的心脏毒性一致。 DOX组的收缩力(+ dP / dt)和LVDP显着降低(p = 0.030)。对照的平均+ dP / dt为2465±183 mm Hg / s,DOX处理的大鼠为1817±177 mm Hg / s,对照的平均LVDP为92.4 mm Hg,DOX处理的大鼠为78.7 mm Hg。在DOX组的治疗过程中,分数缩短(FS)超声心动图测量值显着降低(p = 0.028,FS = 32.8%,n = 5),而对照组则没有(p = 0.209,FS = End)。 50.7%,n = 5)。结论:荧光指示剂稀释法可检测化疗后通透性的变化。这些变化与化学疗法组中观察到的其他心功能测量结果一致。在开发具有降低的心脏毒性的化学疗法药物时,应考虑对内皮层的影响,我们在孤立的心脏装置中测量通透性的方法在测试新药替代品时可能很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号